Aixin Life International, INC
Market Movers (8-K)
OQB
Aixin Life International, Inc. announced the resignation of director Xinliang Li from its Board, effective May 18, 2026.
OQB
Aixin Life International, Inc. has appointed Qiyu Jiang as a new member of the Board of Directors and as Company Secretary.
OQB
AIXIN LIFE International, Inc. announced the resignation of Mr. Yao-te Wang as a director and his removal from all officer positions, effective January 26, 2026.
OQB
Aixin Life International files an amended report to restate its 2021 and 2020 financial statements due to accounting errors related to acquisitions and capital contributions.
Worse than expected
OQB
Aixin Life International, Inc. announces it will restate its 2021 financial statements due to accounting errors related to prior acquisitions and capital contributions.
Worse than expected
OQB
Aixin Life International, Inc. announces it will restate its 2021 financial statements due to accounting errors related to prior acquisitions and capital contributions.
Worse than expected
Quarterly Earnings (10-Q)
OQB
AIXIN Life International, Inc. reported a significant decrease in revenue and an increased net loss for the nine months ended September 30, 2025, raising substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OQB
AIXIN LIFE INTERNATIONAL, INC. reports a 61% revenue decline and increased losses, raising substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OQB
AIXIN LIFE INTERNATIONAL, INC. (AIXN) reported a significant 53% drop in total revenue and a 20% increase in net loss for the first quarter of 2025, raising substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
OQB
AiXin Life International experienced a decrease in revenue and an increased net loss in the third quarter of 2024, impacted by economic challenges and shifts in business operations.
Worse than expected
Capital raise
OQB
AiXin Life International's Q2 2024 results show a decrease in overall revenue, primarily due to declines in direct sales and hotel revenue, partially offset by growth in manufacturing and sales.
Worse than expected
Capital raise
OQB
10-Q: AiXin Life International Reports Q1 2024 Results: Revenue Up, Losses Persist Amid Operational Shifts
AiXin Life International saw a revenue increase in Q1 2024, but losses continued due to rising operating costs and expenses.
Worse than expected
Capital raise
Annual Reports (10-K)
OQB
AiXin Life International reports a significant decline in annual revenue and continues to face substantial going concern risks.
Worse than expected
Capital raise
OQB
AiXin Life International's FY24 results reveal a revenue decrease primarily due to declines in direct sales and hotel revenue, partially offset by growth in manufacturing and sales.
Capital raise
Worse than expected
OQB
AiXin Life International saw a 51% increase in revenue for fiscal year 2023, driven by growth in product sales, pharmacies, and hotel operations.
Worse than expected
Capital raise
New Public Companies (S-1)
OQB
Aixin Life International aims to raise capital through a public offering of common stock to support its health and wellness business expansion in China.
Capital raise
OQB
Aixin Life International aims to raise capital through a public offering of common stock to support its health and wellness product development and expansion.
Capital raise